20 LATEST RESOURCES (455 INDEXED)
Pre-Exposure Prophylaxis among Gay, Bisexual, and Other Men Who Have Sex with Men in Ottawa: A Real World View with Benefits Beyond HIV Risk Reduction · September 2021
Articles
NCBI>International Journal of Sexual Health
Facilitators and Barriers of HPV Vaccine Acceptance, Initiation, and Completion among LGBTQ Community in the U.S.: A Systematic Review · October 2021
Articles
NCBI>International Journal of Sexual Health
Anti-Inflammatory Action of Antidepressants: Investigating the Longitudinal Effect of Antidepressants on White Blood Cell Count · December 2022
Articles
NCBI>Complex Psychiatry
Identifying High-Risk Comorbidities Associated with Opioid Use Patterns Using Electronic Health Record Prescription Data · June 2022
Articles
NCBI>Complex Psychiatry
Strategies for Treatment of Disease-Associated Dementia Beyond Alzheimer’s Disease: An Update · February 2023
Articles
NCBI>Current Neuropharmacology
Neuropharmacology of Alcohol Addiction with Special Emphasis on Proteomic Approaches for Identification of Novel Therapeutic Targets · January 2023
Articles
NCBI>Current Neuropharmacology
Differential Response to Three Antidepressants in Patients with Major Depressive Episode Who Suffered COVID-19-Related Trauma · November 2022
Articles
NCBI>Current Neuropharmacology
Antidepressant Prescription for Major Depressive Disorder: Results from a Population-Based Study in Italy · November 2022
Articles
NCBI>Current Neuropharmacology
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-Based Study in Italy · March 2023
Articles
NCBI>Current Neuropharmacology
Enhancing Psychological Interventions for Post-Traumatic Stress Disorder (PTSD) Treatment with Memory Influencing Drugs · March 2023
Articles
NCBI>Current Neuropharmacology
Early Efficacy of Antipsychotic Medications at Week 2 Predicts Subsequent Responses at Week 6 in a Large-Scale Randomized Controlled Trial · February 2023
Articles
NCBI>Current Neuropharmacology
Treatment of Autism Spectrum Disorders by Mitochondrial-Targeted Drug: Future of Neurological Diseases Therapeutics · April 2023
Articles
NCBI>Current Neuropharmacology
Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder · March 2023
Articles
NCBI>Current Neuropharmacology
Pharmacological Strategies for Bipolar Disorders in Acute Phases and Chronic Management with a Special Focus on Lithium, Valproic Acid, and Atypical Antipsychotics · March 2023
Articles
NCBI>Current Neuropharmacology
Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management · March 2023
Articles
NCBI>Current Neuropharmacology
Beyond Its Psychiatric Use: The Benefits of Low-Dose Lithium Supplementation · March 2023
Articles
NCBI>Current Neuropharmacology
Implication of Hippocampal Neurogenesis in Autism Spectrum Disorder: Pathogenesis and Therapeutic Implications · September 2023
Articles
NCBI>Current Neuropharmacology
Therapeutic Appropriateness of Cariprazine in the Management of Schizophrenia: Experts’ Opinion Using a Delphi Approach · September 2023
Articles
NCBI>Current Neuropharmacology
Update on Pharmacological Treatment for Comorbid Major Depressive and Alcohol Use Disorders: The Role of Extended-Release Trazodone · September 2023
Articles
NCBI>Current Neuropharmacology
Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature · September 2023
Articles
NCBI>Current Neuropharmacology